FDA Recalls 21,000 Faulty Medtronic Pacemakers

Law360, New York (June 11, 2009, 12:00 AM EDT) -- Medtronic Inc. is facing another recall, this time because of Kappa- and Sigma-brand pacemakers that the U.S. Food and Drug Administration said Thursday could fail because of wiring problems.

In the FDA's announcement of the Class I recall, it warned consumers and physicians that the pacemakers might fail because of a separation of the wires that connect the electric circuit to other components, including the battery.

The affected pacemakers may cause symptoms associated with abnormal heart rate, including fainting or light-headedness. In severe, but rare, cases...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.